SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-14-008659
Filing Date
2014-02-14
Accepted
2014-02-13 17:49:49
Documents
1
Group Members
TL VENTURES INC., AS ADMINISTRATORTL VENTURES L.P., AS INVESTMENT MANAGERTL VENTURES MANAGER LLCTL VENTURES V INTERFUND LIQUIDATING TRUST

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G v368333_sc13g.htm SC 13G 101811
  Complete submission text file 0001144204-14-008659.txt   103506
Mailing Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540 (609) 243-0123
Celator Pharmaceuticals Inc (Subject) CIK: 0001327467 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87438 | Film No.: 14608257
SIC: 2834 Pharmaceutical Preparations

Mailing Address 435 DEVON PARK DRIVE 700 BUILDING WAYNE PA 19087
Business Address 435 DEVON PARK DRIVE 700 BUILDING WAYNE PA 19087 610-977-7540
TL Ventures V Liquidating Trust (Filed by) CIK: 0001566852 (see all company filings)

IRS No.: 233051374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G